TrialPsychopharmacology2021

An experimental medicine study of the phosphodiesterase-4 inhibitor, roflumilast, on working memory-related brain activity and episodic memory in schizophrenia patients.

James Gilleen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.